10-Q Filing

REGENXBIO Inc. CIK: 1590877 Q1 2021

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-024116`
Period End Date	20210331
Filing Date	20210505
Fiscal Year	2021
Fiscal Period	Q1
XBRL Instance	rgnx-10q_20210331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 36 Cash Flow Statement 67 Stockholders Equity 19

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$338.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$291.48M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$137.31M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$149.40M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$43.00M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$41.04M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$13.84M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.51M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.51M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.95M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.88M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	37.48M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.51M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$531.20M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$498.64M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	37.48M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$215.60M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$46.81M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$3.27M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$2.86M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$56.47M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$89.34M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$62.61M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$63.81M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$1.33M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$9.07M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.28M	USD	Point-in-time
Total assets	`Assets`	$708.16M	USD	Point-in-time
Total assets	`Assets`	$879.44M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.62M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.31M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$49.08M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$41.60M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$449.00K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$395.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.84M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.50M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$28.81M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$18.79M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$83.96M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$81.45M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.73M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$3.78M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$70.15M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$75.08M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$161.72M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$174.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$524.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$448.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$330.41M	USD	Point-in-time
Total liabilities	`Liabilities`	$324.94M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, and no shares issued and outstanding at March 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at March 31, 2020 and December 31, 2019; 37,190 and 36,992 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$667.18M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$895.08M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.37M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-360.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-289.07M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-339.21M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$554.50M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$420.15M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$377.75M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$450.20M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$879.44M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$708.16M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$17.64M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$18.88M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$4.85M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$3.41M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$37.03M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$39.72M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$14.83M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$17.84M	USD	1 Quarter
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$515.00K	USD	1 Quarter
Provision for credit losses and other	`ProvisionForCreditLossesAndOther`	$67.00K	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$55.34M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$62.93M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-44.04M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.70M	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$29.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$848.00K	USD	1 Quarter
Investment income (loss)	`InvestmentIncomeNet`	$580.00K	USD	1 Quarter
Investment income (loss)	`InvestmentIncomeNet`	$-3.19M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.70M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.09M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-2.34M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-50.13M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-40.04M	USD	1 Quarter
Income Tax Expense	`IncomeTaxExpenseBenefit`	$4.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-50.14M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-40.04M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-785.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.01M	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-1.01M	USD	1 Quarter
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-785.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-51.15M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-40.82M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.08	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.20	USD	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.10M	shares	1 Quarter
Weighted-average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	41.82M	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-50.14M	USD	1 Quarter
Net loss	`ProfitLoss`	$-40.04M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$8.02M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$9.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.93M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$1.99M	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	-	USD	1 Quarter
Provision for credit losses	`ProvisionForOtherCreditLosses`	$565.00K	USD	1 Quarter
Net amortization of premiums on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.29M	USD	1 Quarter
Net amortization of premiums on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-39.00K	USD	1 Quarter
Net realized and unrealized losses (gains) on marketable securities	`NetRealizedOrUnrealizedGainLossOnMarketableSecurities`	$-5.11M	USD	1 Quarter
Net realized and unrealized losses (gains) on marketable securities	`NetRealizedOrUnrealizedGainLossOnMarketableSecurities`	$7.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$848.00K	USD	1 Quarter
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$29.00K	USD	1 Quarter
Non-cash interest expense	`NonCashInterestExpense`	$6.70M	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-25.00K	USD	1 Quarter
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$154.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.74M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.62M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$3.33M	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$947.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$873.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.83M	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-703.00K	USD	1 Quarter
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-1.23M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-1.71M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$3.79M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$278.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$3.06M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-10.54M	USD	1 Quarter
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-3.81M	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-851.00K	USD	1 Quarter
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$4.24M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-38.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.16M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.57M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.13M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$233.63M	USD	1 Quarter
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$30.69M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.47M	USD	1 Quarter
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$60.91M	USD	1 Quarter
Sales of marketable equity securities	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$7.12M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.63M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.02M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-214.18M	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$32.71M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.15M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.29M	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$607.00K	USD	1 Quarter
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$627.00K	USD	1 Quarter
Proceeds from public offering of common stock, net of underwriting discounts and commissions	`ProceedsFromIssuancesOfCommonStockNetOfUnderwritingDiscountsAndCommissions`	$216.44M	USD	1 Quarter
Issuance costs for public offerings of common stock	`PaymentsOfStockIssuanceCosts`	$251.00K	USD	1 Quarter
Repayments under liability related to sale of future royalties	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$9.47M	USD	1 Quarter
Transaction costs for sale of future royalties	`PaymentsOfTransactionCostsForSaleOfFutureLoyalties`	$265.00K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.76M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$208.37M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-46.94M	USD	1 Quarter
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-103.00K	USD	1 Quarter
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.74M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$292.81M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.74M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$339.76M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.84M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$292.81M	USD	Point-in-time
Additions to property and equipment through accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$3.78M	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time
Issuance of common stock upon public offering, net of transaction costs	`StockIssuedDuringPeriodValueNewIssues`	$216.06M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.29M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.15M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$627.00K	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$607.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$8.02M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.92M	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-785.00K	USD	1 Quarter
Unrealized loss on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.01M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-40.04M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-50.14M	USD	1 Quarter
Balances	`StockholdersEquity`	$554.50M	USD	Point-in-time
Balances	`StockholdersEquity`	$420.15M	USD	Point-in-time
Balances	`StockholdersEquity`	$377.75M	USD	Point-in-time
Balances	`StockholdersEquity`	$450.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.